Table 1.
Admission Rates as a Function of Treatment Type and Planned Opioid Agonist Treatment
| 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Admissions (Numbers) | ||||||||||
| Total | 286849 | 291589 | 322145 | 343175 | 344510 | 381008 | 360348 | 374032 | 392518 | 435463 |
| Outpatient | 165181 | 169417 | 195645 | 208156 | 215311 | 233453 | 220522 | 228285 | 244564 | 291676 |
| Detoxification | 121668 | 122172 | 126500 | 135019 | 129199 | 147555 | 139826 | 145747 | 147954 | 143787 |
| Opioid Agonist Planned | ||||||||||
| Total | 93319 | 92316 | 101524 | 104089 | 101700 | 104916 | 100920 | 104809 | 118927 | 171827 |
| Outpatient | 79874 | 78294 | 85892 | 84245 | 82758 | 86054 | 82749 | 87393 | 101364 | 156080 |
| Detoxification | 13445 | 14022 | 15632 | 19844 | 18942 | 18862 | 18171 | 17416 | 17563 | 15747 |
| Admissions (Percentages) | ||||||||||
| Outpatient | 57.6 | 58.1 | 60.7 | 60.7 | 62.5 | 61.3 | 61.2 | 61.0 | 62.3 | 67.0 |
| Detoxification | 42.4 | 41.9 | 39.3 | 39.3 | 37.5 | 38.7 | 38.8 | 39.0 | 37.7 | 33.0 |
| Opioid agonist planned, % treatment type | ||||||||||
| Outpatient | 48.4 | 46.2 | 43.9 | 40.5 | 38.4 | 36.9 | 37.5 | 38.3 | 41.4 | 53.5 |
| Detoxification | 11.1 | 11.5 | 12.4 | 14.7 | 14.7 | 12.8 | 13.0 | 11.9 | 11.9 | 11.0 |
| Opioid Agonist Planned, % of all admissions | ||||||||||
| Outpatient | 27.8 | 26.9 | 26.7 | 24.5 | 24.0 | 22.6 | 23.0 | 23.4 | 25.8 | 35.8 |
| Detoxification | 4.7 | 4.8 | 4.9 | 5.8 | 5.5 | 5.0 | 5.0 | 4.7 | 4.5 | 3.6 |
Admissions data based on Treatment Episode Dataset-Admissions. Data present number of admissions treated for primary heroin, non-prescribed methadone, or opiate/synthetics use disorder. Total represents all admissions treated in detoxification or outpatient settings. Detoxification represents 24-hr hospital-based, 24-free standing, or ambulatory detoxifications. Outpatient represents ambulatory non-intensive or intensive outpatient treatment. Opioid agonist treatment indicates whether methadone or buprenorphine was planned (TEDS-A) as part of treatment.